Merz Therapeutics North America has launched “Celebrating the Fighters,” a nationwide U.S. community campaign honoring the resiliency and courage…
Articles by Andrea Lobo
Boston University has been awarded a $2 million research grant from The Michael J. Fox Foundation for Parkinson’s Research…
Researchers at Case Western Reserve University in Cleveland, Ohio, developed a new compound that blocks a harmful interaction between the…
A clinical trial testing Teitur Trophics‘ TT-P34 in Parkinson’s disease will use Neuralight‘s brain function biomarker based on…
A team at Michigan State University (MSU) won two grants to support research into portable devices designed to improve communication…
Light therapy using Celeste, Photopharmics’ investigational photo-neuromodulation device, was seen in a clinical trial to ease nonmotor symptoms in…
The U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) status to NouvNeu001, iRegene Therapeutics’ cell…
BT-267, an LRRK2 inhibitor being developed by Brenig Therapeutics as a treatment for Parkinson’s disease, has reached…
The American Parkinson Disease Association (APDA) is urging U.S. Department of Health and Human Services (HHS) Secretary Robert F.
Herantis Pharma has reported new Phase 1b biomarker data that support the expected mechanism of action of HER-096, its…